FDA Clears Beckman Coulter’s Osteoporosis Blood Test – (05-20-00)



FDA Clears Beckman Coulter’s Osteoporosis Blood Test

What amazes me about this is that several labs in the country have been running tests for bone turnover for YEARS now!! And, even better, they use urine to test the rate at which bone is being broken down. The US Food and Drug Administration (FDA) has granted 510(k) marketing clearance to Beckman Coulter for its Access Ostase blood test for use in managing osteoporosis and Paget’s disease. The new test, known in the industry as a “bone turnover marker,” will be the first automated, serum-based assay sold and updates the firm’s own manual assay, the Hybritech Ostase Test, Beckman Public Affairs Associate Jobe Dubbs told Reuters Health.

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email:



Posted on
Category: Osteoporosis Cures and Bone Health
Disclosure of Material Connection: Some of the links in the post above are “affiliate links.” This means if you click on the link and purchase the item, I will receive an affiliate commission. Regardless, I only recommend products or services I use personally and believe will add value to my readers. I am disclosing this in accordance with the Federal Trade Commission’s 16 CFR, Part 255: “Guides Concerning the Use of Endorsements and Testimonials in Advertising.”